MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,323,121 | -32.1% | 1,706,128 | -0.2% | 0.00% | -33.3% |
| Q2 2023 | $7,843,670 | -5.8% | 1,708,861 | +1.4% | 0.01% | -14.3% |
| Q1 2023 | $8,324,096 | -9.2% | 1,685,191 | +0.4% | 0.01% | 0.0% |
| Q4 2022 | $9,162,682 | -15.9% | 1,678,147 | +0.1% | 0.01% | -30.0% |
| Q3 2022 | $10,899,000 | +38.0% | 1,676,865 | +0.4% | 0.01% | +66.7% |
| Q2 2022 | $7,900,000 | -31.8% | 1,670,163 | +0.8% | 0.01% | -25.0% |
| Q1 2022 | $11,583,000 | – | 1,657,068 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |